Gsa Capital Partners LLP Mustang Bio, Inc. Transaction History

Gsa Capital Partners LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.32 - $8.27 $184,335 - $4.76 Million	-576,047 Reduced 58.96%	401,048 $158,000
Q3 2022 Nov 14, 2022	BUY	$0.46 - $7.2 $26,022 - $407,304	56,570 Added 6.15%	977,095 $459,000
Q2 2022 Aug 09, 2022	SELL	$0.58 - $1.13 $171,633 - $334,389	-295,920 Reduced 24.33%	920,525 $539,000
Q1 2022 May 11, 2022	SELL	$0.73 - $1.81 $74,427 - $184,538	-101,955 Reduced 7.73%	1,216,445 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $1.26 Million - $2 Million	758,185 Added 135.34%	1,318,400 $2.19 Million
Q3 2021 Nov 12, 2021	BUY	$2.58 - $3.36 $779,301 - $1.01 Million	302,055 Added 117.0%	560,215 $1.51 Million
Q2 2021 Aug 05, 2021	BUY	$2.7 - $3.81 $49,769 - $70,229	18,433 Added 7.69%	258,160 $857,000
Q1 2021 May 10, 2021	BUY	$3.02 - $5.16 $147,632 - $252,246	48,885 Added 25.62%	239,727 $796,000
Q4 2020 Feb 03, 2021	BUY	$2.66 - $4.18 $107,998 - $169,712	40,601 Added 27.02%	190,842 $722,000
Q3 2020 Nov 06, 2020	BUY	$3.01 - $3.88 $324,715 - $418,570	107,879 Added 254.66%	150,241 $473,000
Q2 2020 Aug 11, 2020	BUY	$2.33 - $4.6 $2,124 - $4,195	912 Added 2.2%	42,362 $135,000
Q1 2020 May 12, 2020	BUY	$1.91 - $4.52 $79,169 - $187,353	41,450 New	41,450 $111,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.